IPCHS. Integrated People-Centred Health Services


Contents tagged: drug-resistant tuberculosis

Aug. 30, 2016 Europe Practice

Introducing compassionate use treatment for extensively drug-resistant tuberculosis in Armenia

Compassionate use TB treatment with the experimental drug Bedaquiline was introduced by MSF in partnership with the Government of Armenia to expand treatment options available to XDR-TB patients; MSF’s prior experience of compassionate use initiatives in other contexts supported the initiative’s effective implementation and provided an immediate solution to the lack of available treatment options; donor support and a close partnership with the Ministry of Health allowed initial barriers, including the lack of a comprehensive legal framework, to be overcome; closely aligning reforms with ongoing programmes reduced the investment needed in new infrastructure and helped secure greater professional acceptance for activities.

Jan. 10, 2022 Eastern Mediterranean Publication

Person-centred care and short oral treatment for rifampicin-resistant tuberculosis improve retention in care in Kandahar, Afghanistan

Aknowledging that people living with TB face multiple challenges in addition to TB disease and that better access to new diagnostic or treatment tools alone cannot improve RR-TB care outcomes, person-centred care has been introduced as one of the pillars of the EndTB strategy, which calls for integration of health services, inclusion of social support as part of clinical care. Therefore, person-centred care delivery and treatment regimens were adapted to better fit specific contextual challenges and the needs of the target population, retention in care improved among people with RR-TB in Kandahar, Afghanistan.